Ç. Yildiz And S. A. Bakkaloglu, "A grey zone in canakinumab tapering: dose reduction or interval prolongation?," RHEUMATOLOGY , 2024
Yildiz, Ç. And Bakkaloglu, S. A. 2024. A grey zone in canakinumab tapering: dose reduction or interval prolongation?. RHEUMATOLOGY .
Yildiz, Ç., & Bakkaloglu, S. A., (2024). A grey zone in canakinumab tapering: dose reduction or interval prolongation?. RHEUMATOLOGY .
Yildiz, ÇİSEM, And SEVCAN AZİME BAKKALOĞLU EZGÜ. "A grey zone in canakinumab tapering: dose reduction or interval prolongation?," RHEUMATOLOGY , 2024
Yildiz, ÇİSEM Y. And Bakkaloglu, SEVCAN A. . "A grey zone in canakinumab tapering: dose reduction or interval prolongation?." RHEUMATOLOGY , 2024
Yildiz, Ç. And Bakkaloglu, S. A. (2024) . "A grey zone in canakinumab tapering: dose reduction or interval prolongation?." RHEUMATOLOGY .
@article{article, author={ÇİSEM YILDIZ YILDIRIM And author={SEVCAN AZİME BAKKALOĞLU EZGÜ}, title={A grey zone in canakinumab tapering: dose reduction or interval prolongation?}, journal={RHEUMATOLOGY}, year=2024}